Generation of a live attenuated influenza A vaccine by proteolysis targeting-Reference-Cited by-同舟云学术

Generation of a live attenuated influenza A vaccine by proteolysis targeting

Published:2022-07-04 Issue:9 Volume:40 Page:1370-1377
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Si Longlong^ORCID,Shen Quan,Li Jing,Chen Li,Shen Jinying,Xiao Xue,Bai Haiqing^ORCID,Feng Tang,Ye Adam Yongxin,Li Le,Zhang Chunhe,Li Zhen,Wang Ping,Oh Crystal Yuri,Nurani Atiq^ORCID,Niu Siwen,Zhang Chengxin^ORCID,Wei Xiaoqiong,Yuan Wanqiong,Liao Hao,Huang Xiaojie,Wang Ning,Tian Wen-xia,Tian Hongwei,Li Li,Liu Xiaoheng,Plebani Roberto

Funder

National Natural Science Foundation of China

Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://www.nature.com/articles/s41587-022-01381-4.pdf

Reference54 articles.

1. Yamayoshi, S. & Kawaoka, Y. Current and future influenza vaccines. Nat. Med. 25, 212–220 (2019).

2. Blanco-Lobo, P., Nogales, A., Rodriguez, L. & Martinez-Sobrido, L. Novel approaches for the development of live attenuated influenza vaccines. Viruses 11, 190 (2019).